Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
| Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Hypertension and blood pressure in the Quality and Outcomes Framework (QOF) | blood-pressure-qof | 5377 | TPP | 2/2 | Milan Wiedemann | 4 years, 5 months ago 10 February 2022 11:36:48 UTC | View, Job request 5377 |
| Failed | Assessing effectiveness of 3rd / booster COVID-19 vaccine doses in England | booster-effectiveness_main | 5376 | TPP | 54/60 | Will Hulme | 4 years, 5 months ago 10 February 2022 11:16:37 UTC | View, Job request 5376 |
| Failed | Assessing effectiveness of 3rd / booster COVID-19 vaccine doses in England | booster-effectiveness_main | 5373 | TPP | 0/12 | Will Hulme | 4 years, 5 months ago 10 February 2022 10:05:11 UTC | View, Job request 5373 |
| Failed | Assessing effectiveness of 3rd / booster COVID-19 vaccine doses in England | booster-effectiveness_main | 5371 | TPP | 12/14 | Will Hulme | 4 years, 5 months ago 10 February 2022 08:28:38 UTC | View, Job request 5371 |
| Failed | Assessing effectiveness of 3rd / booster COVID-19 vaccine doses in England | booster-effectiveness_main | 5370 | TPP | 11/15 | Will Hulme | 4 years, 5 months ago 10 February 2022 07:12:05 UTC | View, Job request 5370 |
| Succeeded | Hypertension and blood pressure in the Quality and Outcomes Framework (QOF) | blood-pressure-qof | 5369 | TPP | 2/2 | Milan Wiedemann | 4 years, 5 months ago 10 February 2022 00:25:34 UTC | View, Job request 5369 |
| Failed | Assessing effectiveness of 3rd / booster COVID-19 vaccine doses in England | booster-effectiveness_main | 5368 | TPP | 21/26 | Will Hulme | 4 years, 5 months ago 09 February 2022 22:23:20 UTC | View, Job request 5368 |
| Succeeded | Long COVID-19 Sick Notes | long-covid-sick-notes | 5364 | TPP | 1/1 | Robin Park | 4 years, 5 months ago 09 February 2022 17:11:35 UTC | View, Job request 5364 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5359 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 16:15:14 UTC | View, Job request 5359 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5358 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 15:37:01 UTC | View, Job request 5358 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5356 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 14:12:31 UTC | View, Job request 5356 |
| Failed | Long COVID-19 Sick Notes | long-covid-sick-notes | 5354 | TPP | 0/1 | Robin Park | 4 years, 5 months ago 09 February 2022 13:49:32 UTC | View, Job request 5354 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5353 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 13:44:37 UTC | View, Job request 5353 |
| Succeeded | Long COVID-19 Sick Notes | long-covid-sick-notes | 5351 | TPP | 1/1 | Robin Park | 4 years, 5 months ago 09 February 2022 12:52:19 UTC | View, Job request 5351 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5350 | TPP | 0/1 | Millie Green | 4 years, 5 months ago 09 February 2022 12:38:08 UTC | View, Job request 5350 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5349 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 12:27:39 UTC | View, Job request 5349 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5346 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 12:04:02 UTC | View, Job request 5346 |
| Succeeded | Long COVID-19 Sick Notes | long-covid-sick-notes | 5345 | TPP | 1/1 | Robin Park | 4 years, 5 months ago 09 February 2022 11:50:21 UTC | View, Job request 5345 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5344 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 11:42:16 UTC | View, Job request 5344 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5342 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 11:23:33 UTC | View, Job request 5342 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5341 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 11:20:23 UTC | View, Job request 5341 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5340 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 11:13:31 UTC | View, Job request 5340 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5339 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 11:00:12 UTC | View, Job request 5339 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5338 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 10:44:52 UTC | View, Job request 5338 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-draft-report | 5337 | TPP | 1/1 | Millie Green | 4 years, 5 months ago 09 February 2022 10:41:51 UTC | View, Job request 5337 |